Hong Kong-listed biotechnology stocks retreated, with Everest Medicines (01952.HK) falling nearly 10%, CanSino Biologics (06185.HK) falling over 8%, and YunKang Group (02325.HK) falling over 7%.
2026-08-21
Hong Kong-listed biotechnology stocks retreated, with Everest Medicines (01952.HK) falling nearly 10%, CanSino Biologics (06185.HK) falling over 8%, and YunKang Group (02325.HK) falling over 7%.